Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Arizona Cancer Center

Arizona Cancer Center Newsletter

U of A cancer lab turns to crowdfunding to support research 15 Jul 2025 09:01 GMT
… credit for their work. The Arizona Cancer Center was founded almost 50 years …
University of Arizona Cancer Center receives re-accreditation for breast care 07 Mar 2025 17:07 GMT
… Medicine's University of Arizona Cancer Center (UACC) has been re-accredited …
Kiromic BioPharma Activates the University of Arizona Cancer Center as the Fifth Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial 19 Sep 2024 20:58 GMT
… ”) announces that the University of Arizona Cancer Center (UACC) has been activated as … . About the University of Arizona Cancer Center The University of Arizona Cancer Center (UACC) is the …
Cleveland Clinic and MeCo Diagnostics publish first-ever study of mechanical conditioning in circulating tumor cells 26 Jun 2025 17:09 GMT
… provided by the University of Arizona Cancer Center and the USC Norris Comprehensive …
Dr. Tony Hunter awarded 2025 Szent-Györgyi Prize for pioneering cancer research 24 Jun 2025 15:47 GMT
… ., Ph.D., The University of Arizona Cancer Center For More Information: https:…
i3 Health and Oncology Data Advisor Publish New Biliary Tract Cancer Guidance in 'Hepatology Communications' 17 Jun 2025 15:00 GMT
… Medicine at the University of Arizona Cancer Center • Melinda Bachini, Chief Patient Officer … Oncology at the University of Arizona Cancer Center • Xuchen Zhang, MD, PhD, Professor …
Actuate Therapeutics Shares Highlights from KOL Event on Positive Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer 02 Jun 2025 13:00 GMT
… , MD, MS, FASCO, University of Arizona Cancer Center; Tanios Bekaii-Saab, MD, FACP …
Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer 31 May 2025 20:30 GMT
… , MD, MS, FASCO, University of Arizona Cancer Center; and Colin Weekes, MD, PhD …
$2.4 Million Grant Advances Optical Imaging Technology to Detect Chemotherapy-Induced Peripheral Neuropathy 22 May 2025 19:56 GMT
… by Joshua Elz, University of Arizona Cancer Center Keywords: Chemotherapy, Biomarkers, Medical treatments …
Actuate Therapeutics Announces Details for 2025 ASCO Annual Meeting Presentation on Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer 22 May 2025 21:05 GMT
… , MD, MS, FASCO, University of Arizona Cancer Center, and Colin Weekes, MD, PhD …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS